Plectasin has antibacterial activity and no affect on cell viability or IL-8 production

Biochemical and Biophysical Research Communications

Volumn 374, Issue 4, 2008, Pages 709-713

  Hara, Shintaro ^a   Mukae, Hiroshi ^a   Sakamoto, Noriho ^a   Ishimoto, Hiroshi ^a   Amenomori, Misato ^a   Fujita, Hanako ^a   Ishimatsu, Yuji ^a   Yanagihara, Katsunori ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

A549 cell; Antibacterial activity; Cytokine induction; Cytotoxicity; Defensin; Human defensins; Human neutrophil peptide 1; Interleukin 8 induction; Normal human bronchial epithelial cell; Normal human lung fibroblast; Plectasin

Indexed keywords

DEFENSIN; INTERLEUKIN 8; PLECTASIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BRONCHI; CELL LINE; CELL SURVIVAL; DEFENSINS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; STREPTOCOCCUS PNEUMONIAE;

EID: 49449101582     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.093     Document Type: Article

References (32)

1. Selsted M.E., and Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6 (2005) 551-557
2. Welling M.M., Hiemstra P.S., van den Barselaar M.T., Paulusma-Annema A., Nibbering P.H., Pauwels E.K., and Calame W. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J. Clin. Invest. 102 (1998) 1583-1590
3. Kalita A., Verma I., and Khuller G.K. Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J. Infect. Dis. 190 (2004) 1476-1480
4. Hancock R.E., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24 (2006) 1551-1557
5. Marr A.K., Gooderham W.J., and Hancock R.E. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6 (2006) 468-472
6. Yang D., Biragyn A., Kwak L.W., and Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 (2002) 291-296
7. Raj P.A., and Dentino A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206 (2002) 9-18
8. Bowdish D.M., Davidson D.J., and Hancock R.E. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6 (2005) 35-51
9. Maisetta G., Di Luca M., Esin S., Florio W., Brancatisano F.L., Bottai D., Campa M., and Batoni G. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29 (2008) 1-6
10. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11 (1993) 105-128
11. Sakamoto N., Mukae H., Fujii T., Ishii H., Yoshioka S., Kakugawa T., Sugiyama K., Mizuta Y., Kadota J., Nakazato M., and Kohno S. Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L508-L513
12. Yoshioka S., Mukae H., Ishii H., Kakugawa T., Ishimoto H., Sakamoto N., Fujii T., Urata Y., Kondo T., Kubota H., Nagata K., and Kohno S. Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts. Life Sci. 80 (2007) 1839-1845
13. Zhang H., Porro G., Orzech N., Mullen B., Liu M., and Slutsky A.S. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L947-L954
14. Mukae H., Iiboshi H., Nakazato M., Hiratsuka T., Tokojima M., Abe K., Ashitani J., Kadota J., Matsukura S., and Kohno S. Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. Thorax 57 (2002) 623-628
15. Ashitani J., Mukae H., Arimura Y., Sano A., Tokojima M., and Nakazato M. High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Life Sci. 75 (2004) 1123-1134
16. Van Wetering S., Mannesse-Lazeroms S.P., Dijkman J.H., and Hiemstra P.S. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J. Leukoc. Biol. 62 (1997) 217-226
17. Thevissen K., Kristensen H.H., Thomma B.P., Cammue B.P., and Francois I.E. Therapeutic potential of antifungal plant and insect defensins. Drug Discov. Today 12 (2007) 966-971
18. Zhu S. Discovery of six families of fungal defensin-like peptides provides insights into origin and evolution of the CSalphabeta defensins. Mol. Immunol. 45 (2008) 828-838
19. Mygind P.H., Fischer R.L., Schnorr K.M., Hansen M.T., Sonksen C.P., Ludvigsen S., Raventos D., Buskov S., Christensen B., De Maria L., Taboureau O., Yaver D., Elvig-Jorgensen S.G., Sorensen M.V., Christensen B.E., Kjaerulff S., Frimodt-Moller N., Lehrer R.I., Zasloff M., and Kristensen H.H. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437 (2005) 975-980
20. The Clinical and Laboratory Standards Institute, Guideline M7-A7: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, The Clinical and Laboratory Standards Institute, 2006.
21. Nakajima Y., Ishibashi J., Yukuhiro F., Asaoka A., Taylor D., and Yamakawa M. Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria. Biochim. Biophys. Acta 1624 (2003) 125-130
22. Gabay J.E., Heiple J.M., Cohn Z.A., and Nathan C.F. Subcellular location and properties of bactericidal factors from human neutrophils. J. Exp. Med. 164 (1986) 1407-1421
23. Goldman M.J., Anderson G.M., Stolzenberg E.D., Kari U.P., Zasloff M., and Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88 (1997) 553-560
24. B. Dickinson, Mueller Hinton II Broth (Cation-Adjusted), Difco/BBL Manual, Becton, Dickinson and Co., 2003.
25. Takemura H., Kaku M., Kohno S., Hirakata Y., Tanaka H., Yoshida R., Tomono K., Koga H., Wada A., Hirayama T., and Kamihira S. Evaluation of susceptibility of Gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob. Agents Chemother. 40 (1996) 2280-2284
26. Harwig S.S., Ganz T., and Lehrer R.I. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 236 (1994) 160-172
27. Aarbiou J., Ertmann M., van Wetering S., van Noort P., Rook D., Rabe K.F., Litvinov S.V., van Krieken J.H., de Boer W.I., and Hiemstra P.S. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J. Leukoc. Biol. 72 (2002) 167-174
28. Baggiolini M., Walz A., and Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84 (1989) 1045-1049
29. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., Oda H., Kawakami K., Fukushima K., Hiratani K., and Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 147 (1993) 153-159
30. Mattoli S., Mattoso V.L., Soloperto M., Allegra L., and Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J. Allergy Clin. Immunol. 87 (1991) 794-802
31. Ashitani J., Mukae H., Nakazato M., Ihi T., Mashimoto H., Kadota J., Kohno S., and Matsukura S. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur. Respir. J. 11 (1998) 104-111
32. Lay F.T., and Anderson M.A. Defensins-components of the innate immune system in plants. Curr. Protein Pept. Sci. 6 (2005) 85-101